The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
08 Apr, 2026, 12.38 AM IST
Biocon Biologics sees Biopharma SHAKTI as major boost for India’s biosimilar ambitionsIndia's biopharmaceutical sector receives a significant boost with the Union Budget's ₹10,000 crore Biopharma SHAKTI programme. This initia...
01 Feb, 2026, 03.21 PM IST
Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
10 May, 2025, 08.31 PM IST
Biocon appoints Peter Bains as Group CEO"I am delighted to welcome Peter to the Biocon Group in the role of Group CEO. Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, C...
18 Sep, 2023, 09.50 PM IST
Devastated to lose my husband: Kiran Mazumdar-Shaw"I am devastated to lose my husband, my mentor and soul mate. I will always be spiritually guided by John as I pursue my purpose. Rest in P...
25 Oct, 2022, 12.31 PM IST
Biocon founder Kiran Mazumdar-Shaw's husband, John Shaw, passes awayBorn in 1949, Shaw served as the Vice Chairman and non-executive director of Biocon and has been on the board since 1999. He was the foreig...
24 Oct, 2022, 07.26 PM IST
Biocon Biologics approves primary equity investment by ADQ worth Rs 555 croreAs per the terms of the proposed agreement, ADQ will invest Rs 555 Crore for a 1.80 per cent minority stake in the biosimilar business, val...
07 Jan, 2021, 08.21 PM IST
Biocon Biologics, Voluntis tie up on digital therapeutics for people with diabetesInsulia provides automated insulin dose recommendations and coaching messages for people with diabetes, while enabling the healthcare team ...
22 Jul, 2020, 12.09 AM IST
Biocon elevates M B Chinappa as CFO of biosimilar subsidiaryM B Chinappa, who is going to play an important role in Biocon Biologics’ journey towards becoming a global leader in biologics, has been t...
06 Jan, 2020, 07.56 PM IST
Biocon gets EIR from USFDA for Bengaluru biologics unitBiopharma major Biocon reportedly received an Establishment Inspection Report (EIR) from US-FDA for its biologics drug product unit at Beng...
05 Nov, 2019, 11.58 AM IST
- Licensing deals help Biocon post healthy Q3 nos
Biocon's third quarter consolidated net profit rose 24% to 100.75 helped by inflows from licensing deals with global biggies Pfizer and Myl...
21 Jan, 2011, 12.45 AM IST
- Biocon Q4 profit zooms to Rs 81 crore
Biotechnology major Biocon's net profit for the fourth quarter rose sharply after revenues increased and a forex loss of Rs 41.4 crore had ...
30 Apr, 2010, 02.01 AM IST
- Biocon acquires 49% Cuban partner CIMAB’s stake in JV
Biocon has fully acquired the joint venture Biocon Biopharmaceuticals from its Cuban partner CIMAB.
06 Apr, 2010, 04.33 AM IST
- Biocon LTD signs MoU with Malaysian-based BiotechCorp
Biocon Limited today signed an MoU with Malaysia's Biotechnology Corporation (BiotechCorp) to explore collaboration and potential investmen...
22 Jan, 2010, 09.12 PM IST
- Biocon in licensing deals in N America, Europe
Under the agreement, Biocon will receive an upfront licensing fee, and following approval in the licensed territories, royalties from sales.
18 Jul, 2007, 11.31 AM IST
- Biocon forms JV with Abu Dhabi-based co
The joint-venture with Neopharma is an important milestone for Biocon's global foray.
05 Jan, 2007, 12.50 PM IST